These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 16012196)

  • 41. P2 purinergic receptors signal to STAT3 in astrocytes: Difference in STAT3 responses to P2Y and P2X receptor activation.
    Washburn KB; Neary JT
    Neuroscience; 2006 Oct; 142(2):411-23. PubMed ID: 16905269
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Purinergic signaling negatively regulates activity of an olfactory receptor in an odorant-dependent manner.
    Yu Y; Zhang C
    Neuroscience; 2014 Sep; 275():89-101. PubMed ID: 24928349
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Characterization of contractile P2 receptors in human coronary arteries by use of the stable pyrimidines uridine 5'-O-thiodiphosphate and uridine 5'-O-3-thiotriphosphate.
    Malmsjö M; Hou M; Harden TK; Pendergast W; Pantev E; Edvinsson L; Erlinge D
    J Pharmacol Exp Ther; 2000 Jun; 293(3):755-60. PubMed ID: 10869373
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Increase of intracellular Ca2+ by P2X and P2Y receptor-subtypes in cultured cortical astroglia of the rat.
    Fischer W; Appelt K; Grohmann M; Franke H; Nörenberg W; Illes P
    Neuroscience; 2009 Jun; 160(4):767-83. PubMed ID: 19289154
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Fidelity in functional coupling of the rat P2Y1 receptor to phospholipase C.
    Schachter JB; Boyer JL; Li Q; Nicholas RA; Harden TK
    Br J Pharmacol; 1997 Nov; 122(6):1021-4. PubMed ID: 9401764
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Pharmacological profiles of cloned mammalian P2Y-receptor subtypes.
    von Kügelgen I
    Pharmacol Ther; 2006 Jun; 110(3):415-32. PubMed ID: 16257449
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Partners for adenosine A1 receptors.
    Franco R; Ciruela F; Casadó V; Cortes A; Canela EI; Mallol J; Agnati LF; Ferré S; Fuxe K; Lluis C
    J Mol Neurosci; 2005; 26(2-3):221-32. PubMed ID: 16012195
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Regulation of P2Y1 receptor traffic by sorting Nexin 1 is retromer independent.
    Nisar S; Kelly E; Cullen PJ; Mundell SJ
    Traffic; 2010 Apr; 11(4):508-19. PubMed ID: 20070609
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Purinergic transmission in blood vessels.
    Ralevic V; Dunn WR
    Auton Neurosci; 2015 Sep; 191():48-66. PubMed ID: 26004513
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The P2Y(1) and P2Y(12) receptors mediate autoinhibition of transmitter release in sympathetic innervated tissues.
    Quintas C; Fraga S; Gonçalves J; Queiroz G
    Neurochem Int; 2009 Dec; 55(7):505-13. PubMed ID: 19447154
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Activation of P2X(7) receptors stimulates the expression of P2Y(2) receptor mRNA in astrocytes cultured from rat brain.
    D'Alimonte I; Ciccarelli R; Di Iorio P; Nargi E; Buccella S; Giuliani P; Rathbone MP; Jiang S; Caciagli F; Ballerini P
    Int J Immunopathol Pharmacol; 2007; 20(2):301-16. PubMed ID: 17624242
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The enteric purinergic P2Y1 receptor.
    Wood JD
    Curr Opin Pharmacol; 2006 Dec; 6(6):564-70. PubMed ID: 16934527
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Differential coupling of the P2Y1 receptor to Galpha14 and Galphaq/11 proteins during the development of the rat salivary gland.
    Baker OJ; Camden JM; Ratchford AM; Seye CI; Erb L; Weisman GA
    Arch Oral Biol; 2006 May; 51(5):359-70. PubMed ID: 16336941
    [TBL] [Abstract][Full Text] [Related]  

  • 54. NF546 [4,4'-(carbonylbis(imino-3,1-phenylene-carbonylimino-3,1-(4-methyl-phenylene)-carbonylimino))-bis(1,3-xylene-alpha,alpha'-diphosphonic acid) tetrasodium salt] is a non-nucleotide P2Y11 agonist and stimulates release of interleukin-8 from human monocyte-derived dendritic cells.
    Meis S; Hamacher A; Hongwiset D; Marzian C; Wiese M; Eckstein N; Royer HD; Communi D; Boeynaems JM; Hausmann R; Schmalzing G; Kassack MU
    J Pharmacol Exp Ther; 2010 Jan; 332(1):238-47. PubMed ID: 19815812
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Synthesis and characterization of a cellular membrane affinity chromatography column containing histamine 1 and P2Y(1) receptors: a multiple G-protein coupled receptor column.
    Moaddel R; Musyimi HK; Sanghvi M; Bashore C; Frazier CR; Khadeer M; Bhatia P; Wainer IW
    J Pharm Biomed Anal; 2010 Jul; 52(3):416-9. PubMed ID: 19608372
    [TBL] [Abstract][Full Text] [Related]  

  • 56. G protein-coupled purinergic P2Y receptor oligomerization: Pharmacological changes and dynamic regulation.
    Guo X; Li Q; Pi S; Xia Y; Mao L
    Biochem Pharmacol; 2021 Oct; 192():114689. PubMed ID: 34274353
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Molecular modeling as a tool to investigate molecular recognition in P2Y receptors.
    Moro S; Jacobson KA
    Curr Pharm Des; 2002; 8(26):2401-13. PubMed ID: 12369952
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The recently deorphanized GPR80 (GPR99) proposed to be the P2Y15 receptor is not a genuine P2Y receptor.
    Abbracchio MP; Burnstock G; Boeynaems JM; Barnard EA; Boyer JL; Kennedy C; Miras-Portugal MT; King BF; Gachet C; Jacobson KA; Weisman GA
    Trends Pharmacol Sci; 2005 Jan; 26(1):8-9. PubMed ID: 15629198
    [No Abstract]   [Full Text] [Related]  

  • 59. Lighting up G protein-coupled purinergic receptors with engineered fluorescent ligands.
    Ciruela F; Fernández-Dueñas V; Jacobson KA
    Neuropharmacology; 2015 Nov; 98():58-67. PubMed ID: 25890205
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Probing GPCR structure: adenosine and P2Y nucleotide receptors.
    Jacobson KA; Costanzi S; Deflorian F
    Methods Enzymol; 2013; 520():199-217. PubMed ID: 23332701
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.